<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Ann N Y Acad Sci. 2005 November ; 1058: 105&#226;&#8364;&#8220;118. <br />  <br />  <br />                            Development resistance RNAi mammalian cells <br />  <br />                            Zhi-Ming Zheng*, Shuang Tang, Mingfang Tao <br />                            HIV AIDS Malignancy Branch, Center Cancer Research, National Cancer Institute, National <br />                            Institutes Health, Bethesda, MD 20892, USA <br />  <br />                            Abstract <br />                                 discovery RNA interference (RNAi) C. elegans plants revolutionized current <br />                                 approaches biology medicine. RNAi silences genes sequence-specific manner                                 actions small pieces double-stranded RNAs (siRNAs miRNAs). RNAi                                 widespread natural phenomenon eukaryotic cells used powerful <br />                                 experimental tool explore gene function. importantly, potential therapeutic <br />                                 applications. Viral gene-specific siRNAs theoretically promising antiviral inhibitors                                 examined broad range medically important viruses.  RNA viruses <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 escape RNAi-mediated suppression counteracting RNAi machinery mutation                                 targeted region, encoding viral suppressors,  DNA viruses counteract RNAi <br />                                 machinery, preferentially using viral suppressors. Cellular factors contribute RNAi <br />                                 resistance; ADAR1 cellular factor responsible editing-mediated RNAi <br />                                 resistance. siRNAs used potent small-molecule inhibitors cellular gene,                                 best way cell maintain expression essential genes long-term survival develop <br />                                 program resist detrimental effects RNAi. <br />  <br />  <br />                            Keywords <br />                                 RNA interference; siRNA; miRNA; gene expression; viral inhibitors; gene therapies <br />  <br />  <br />                            INTRODUCTION <br />                                             RNA interference (RNAi) recently recognized important mechanism                                             controlling gene expression post-transcriptional level19,49 regulating heterochromatin <br />                                             formation genome stability 54,69. RNAi-mediated post-transcriptional gene silencing NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             restrict expression certain genes tissue development cell differentiation. Small <br />                                             RNA duplexes, usually 21 23 nucleotides (nts) size, generated cleavage larger <br />                                             double-stranded (ds) RNAs ribonuclease Dicer 53,75. small RNA duplexes trigger <br />                                             RNAi sequence-specific cleavage degradation homologous single-stranded <br />                                             mRNA suppression mRNA translation 19,28,46. <br />  <br />                                             Based origin function, small RNAs produced Dicer cleavage classified <br />                                             categories: small interfering RNAs (siRNAs) microRNAs (miRNAs).                                             siRNAs miRNAs &#226;&#710;&#188;21- 23-bp duplexes bearing 2-nt overhangs 3&#226;&#8364;&#178; ends.                                             differ siRNAs originate cytoplasm cleavage long dsRNAs perfect <br />                                             base-pairing26,73, miRNAs derived cleavage long, single-stranded <br />                                             primary transcripts containing imperfectly matched hairpin-loop structures. general, primary <br />                                             miRNA transcripts cleaved RNase III-like protein Drosha &#226;&#710;&#188;65 nt stem- <br />  <br />  <br />                            *Corresponding author: HIV AIDS Malignancy Branch, Center Cancer Research, National Cancer Institute, National Institutes <br />                            Health, 10 Center Dr., Rm. 10S 255, Bethesda, MD 20892, USA, Tel. 301-594-1382, Fax: 301-480-8250, email: <br />                            zhengt@exchange.nih.gov <br />                             Zheng et al.                                                                                               Page 2 <br />  <br />  <br />                                           loop pre-miRNAs nucleoplasm34,35 transported Exportin-5                                           cytoplasm 44, processed Dicer &#226;&#710;&#188;21- 23-bp miRNA duplexes <br />                                           imperfect base-pairing. siRNAs miRNAs, strand (antisense) NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           selectively incorporated dsRNA-induced silencing complex (RISC) contains <br />                                           Argonaute (eIF2C), SMN3, proteins 27,46,47 guides selection                                           complementary mRNA cleavage translational inhibition. Recently, Ago 2 shown <br />                                           key component cleavage substrate 27,55. accumulated evidence far <br />                                           indicates siRNAs miRNAs program RISCs equivalently produce similar <br />                                           effects mRNA expression despite somewhat different origins 16,74. <br />  <br />                                           RNAi induced introduction synthetic &#226;&#710;&#188;21- 23-nt siRNA duplexes cells, <br />                                           bypassing requirement processing long dsRNA mediated Dicer 20. RNAi <br />                                           mediated siRNAs miRNAs artificially introduced mammalian cells                                           successfully used knock gene expression suppress viral replication,                                           outcome individual RNAi events varies depending designed siRNAs                                           targeted regions. Efficient silencing target using RNAi approach requires active <br />                                           cell metabolism, cells undergoing exponential growth. transient transfection <br />                                           assays synthetic siRNA duplexes, run RNAi effective dose generally confers <br />                                           detectable suppression target 48-72 hours (Fig. 1). runs                                           RNAi needed achieve extensive longer-lasting suppression.                                           individual siRNA&#226;&#8364;&#8482;s half-life targeted region influence proficiency RNAi, active <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           RISC function cells necessary make suppression effective. Cells                                           exponentially active growth confer efficient siRNA duplexes active <br />                                           RISC function. shown Fig. 1, cells 96 hours culture response RNAi <br />                                           (compare lane 7 lane 6) affected siRNA-mediated p53 suppression. <br />                                           &#226;&#8364;&#339;RNAi resistance&#226;&#8364;? usually refers active processes, discussed  care <br />                                           taken study RNAi RNAi resistance cells appropriate phase growth. <br />  <br />                                           known plant virology plant viruses                                           counteract RNAi plant cells order invade hosts, reports                                           development RNAi resistance mammalian cells came surprise. Approximately 22 <br />                                           silencing suppressors described plant insect viruses;                                           summarized excellent reviews 15,38,68,72. report, emphasize                                           emergence siRNA resistance mechanism counteracts RNAi-mediated gene <br />                                           silencing mammalian cells (Table 1). <br />  <br />                               Development resistance siRNA-mediated viral gene silencing RNA <br />                               virus infections <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           RNA viruses RNA genome single-stranded double-stranded. Viral <br />                                           RNA replication infected cells mediated viral RNA-dependent RNA polymerase <br />                                           (RDRP), produces dsRNA intermediate phase single-stranded RNA viruses. <br />                                           lacks proofreading activity, viral RDRP replicates RNA genome low <br />                                           fidelity, resulting mutation rate order &#226;&#710;&#188;10-4 incorporated <span id='am-12' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-13' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-19' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span>nucleotide</span>.  <br />                                           viral RDRP inherent error frequency order 1 104, depending virus <br />                                           17,36.  conceivable RNA viruses selection pressure escape siRNA- <br />                                           mediated suppression mutation target regions, siRNA-resistant <br />                                           viruses. presumption supported accumulating evidence elegant <br />                                           studies, described  <br />  <br />                                           Using RNAi antiviral therapy considered viruses, including DNA <br />                                           viruses RNA viruses. Poliovirus tested siRNA-mediated <br />                                           sequence-specific inhibition. HeLa cells treated siRNA specific capsid protein  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                             Page 3 <br />  <br />  <br />                                           viral polymerase infection virulent poliovirus produced 1%-3% virus <br />                                           titer observed control-treated cells showed virus plaque formation.                                            poliovirus readily escapes highly effective siRNAs unique point mutations NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           targeted regions 23. emergence siRNA-resistant viruses begins 30-40 hours <br />                                           postinfection. analysis resistant mutants showed RNAi recognition                                           sensitive subtle point mutations central region 3&#226;&#8364;&#178; end target RNA. <br />                                           single point mutation resulting G:U mismatch sufficient virus escape <br />                                           siRNA inhibition 24. Using pool siRNAs simultaneously target multiple sites                                           virus genome good choice prevent emergence resistant viruses. <br />  <br />                                           RNAi demonstrated powerful tool suppressing HIV infection various <br />                                           transient, short-term assays 11,29&#226;&#8364;&#8240;33,48. Recently, resistance RNAi directed HIV-1 <br />                                           noticed siRNA duplexes targeting viral tat 1 nef 12 genes stably <br />                                           expressed human T cells long-term inhibition. RNAi-resistant HIV-1 variants                                           identified deletions substitutions siRNA target regions. mutations, <br />                                           HIV-1 removes RNA target escapes RNAi-mediated inhibition. <br />  <br />                                           Resistance siRNA-mediated suppression La Crosse Virus (LACV) replication                                           noticed 72 hours virus infection 293T cells pre-treated LACV siRNAs <br />                                           61. resistant viruses recovered culture supernatant single double <br />                                           nucleotide changes targeted regions, significantly high frequency portion <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           S segment targeted siRNA LACS103. interestingly, viral nonstructural <br />                                           protein LACV, NSs, appears function RNAi suppressor protein. Cells expressing <br />                                           NSs protein strongly suppress RNAi directed LACV M segment host <br />                                           gene, GAPDH (glyeraldehyde-3-phosphate dehydrogenase) 61. <br />  <br />                                           Tas protein retrovirus primate foamy virus type 1 (PFV-1) recently                                           identified suppressor miR-32, miRNA cellular origin. PFV-1 open reading <br />                                           frame 2 contains target miR-32. counterdefense miR-32-mediated suppression, <br />                                           PFV-1 encodes Tas silencing suppressor enables host cell invasion virus <br />                                           replication 32. <br />  <br />                               Development resistance siRNA-mediated viral gene silencing DNA <br />                               virus infections <br />                                           Compared RNA viruses, designed high rate mutation                                           RNA genome replication, genomes DNA viruses relatively stable, low <br />                                           mutation rate 10-8 10-11 incorporated nucleotide.  resistance RNAi-mediated <br />                                           viral gene silencing mutation target sequence observed DNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           virus infection.  siRNA exert selection pressure pre-existing resistant <br />                                           mutants, exemplified recent report hepatitis B virus (HBV) 70. HBV DNA virus, <br />                                           DNA replicates genomic RNA intermediate utilizes virally encoded <br />                                           reverse transcriptase. Consequently, significant diversity, similar seen                                           RNA viruses, occurs sequences HBV isolates; classified 8 <br />                                           genotypes  H). mutant C genotype contains mutation 3&#226;&#8364;&#178; portion targeted <br />                                           region isolated resistant HBVS1 short hairpin (sh) RNA-mediated RNAi <br />                                           wild-type. mutant preferentially selected presence HBVS1 <br />                                           shRNA Huh-7 cells transfected wild-type mutant HBV-C ratio 9:1 day <br />                                           5 post-transfection 70. <br />  <br />                                           Adenovirus infection result inhibition RNAi, actions                                           virally encoded noncoding RNA, VA1. Adenovirus VA1 RNA &#226;&#710;&#188;160-nt structured RNA <br />                                           highly expressed adenovirus-infected cells (&#226;&#710;&#188;108 molecules/cell) plays important <br />  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                               Page 4 <br />  <br />  <br />                                           roles increasing viral mRNA translation 65 stabilizing ribosome-bound mRNAs 63, <br />                                           64. VA1 RNA enhances viral mRNA translation blocking activation protein kinase R <br />                                           (PKR), usually induced viral dsRNA produced adenoviral replication <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           cycle. Cullen colleagues recently used reporter assay VA1 RNA inhibits <br />                                           RNAi induced shRNAs, does affect RNAi induced synthetic siRNA duplexes. <br />                                           VA1 RNA-mediated inhibition RNAi appears occur inhibition nuclear export <br />                                           shRNA, competition Exportin-5, inhibition Dicer function direct binding                                           Dicer 43. <br />  <br />                                           recent study shRNA-mediated oncogene silencing human papillomavirus 16 <br />                                           (HPV16) cervical cancer cells provides evidence DNA virus escape RNAi <br />                                           (Tang, S., et al., unpublished data). HPV16 contains viral oncogenes encode E6,                                           targets p53 degradation, E7, targets pRB. oncogenes transcribed                                           single E6E7 bicistronic RNA essential genes survival cervical cancer cells. <br />                                           Transfection HPV16-positive cervical cancer cell lines, CaSki SiHa, synthetic <br />                                           siRNA duplex based sequence motif 21 nts HPV16 E6E7 bicistronic RNA <br />                                           effectively suppressed E6 E7 oncogenes, leading stabilization p53                                           increased p21 expression. stably expressed short hairpin RNA cells                                           selection pressure,  siRNA silencing E6 E7 expression efficient                                           early cell passages, inefficient additional cell passages despite continued <br />                                           expression siRNA level. loss siRNA function duplicated NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           cells stable p53 siRNA, cells stable lamin C siRNA, suggesting                                           target-selective. siRNA-resistant cells retain normal siRNA processing, duplex <br />                                           unwinding degradation unwound sense strand, RISC formation, suggesting                                           loss siRNA function occurred later step. Surprisingly, siRNA-resistant cells                                           contain cytoplasmic protein &#226;&#710;&#188;50 kDa specifically characteristically <br />                                           interacted E6E7 siRNA. data indicate potent siRNA targeting essential <br />                                           regulatory gene induce cell develop siRNA resistance production                                           specific protein. <br />  <br />                               Viral proteins mammalian viruses function suppressors RNAi                               non-mammalian cells plants <br />                                           viral proteins expressed mammalian viruses, interferon antagonist proteins <br />                                           influenza virus NS1 (non-structural protein 1), reovirus &#207;&#402;3, vaccinia virus E3L,                                           examined suppressive effects RNAi non-mammalian cells. <br />  <br />                                           Influenza viruses group single-stranded RNA viruses divided types  B, <br />                                           C. influenza virus NS1 protein multifunctional, non-structural protein contains <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           functional domains. domains N-terminal half NS1:                                           responsible translational enhancement influenza virus mRNAs interactions <br />                                           eIF4G, eukaryotic translation initiation factor, essential dsRNA- <br />                                           binding antagonizing interferon induction sequestering dsRNA PKR binding                                           activation. domain, inhibits mRNA processing nuclear-cytoplasmic <br />                                           transport host mRNAs, C-terminal half protein 31. Using plant silencing <br />                                           suppression assay, groups simultaneously demonstrated influenza NS1 protein                                           RNA silencing suppressor plants promotes plant virus pathogenicity potato virus <br />                                           X different plant hosts 3,14. NS1 suppression RNAi requires dsRNA-binding <br />                                           domain protein functional interact siRNAs 3. observations <br />                                           supported independent evidence Ding Palese groups showing                                           NS1 proteins influenza  B, C viruses RNAi suppressors                                           Drosophila cell-based, nodaviral silencing screen assay. study showed NS1  <br />  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                            Page 5 <br />  <br />  <br />                                           influenza viruses suppresses RNAi Drosophila cells N-terminal dsRNA- <br />                                           binding domain binding siRNAs 39. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Reoviruses group dsRNA viruses. Reovirus outer shell polypeptide &#207;&#402;3                                           best-characterized dsRNA binding proteins. Like influenza virus NS1, reovirus &#207;&#402;3 carries <br />                                           conserved dsRNA-binding motifs binds dsRNAs vitro vivo. Accordingly, <br />                                           reovirus &#207;&#402;3 protein sequesters dsRNA PKR binding prevents activation                                           dsRNA. tested plant cells, &#207;&#402;3 showed strong RNAi suppression, failed                                           sequester miRNA precursors 40.  data suggest reovirus &#207;&#402;3 protein                                           capable counteracting RNAi-mediated gene silencing addition inhibiting PKR- <br />                                           mediated responses. <br />  <br />                                           Vaccinia virus member poxvirus family DNA genome replicates                                           cytoplasm viral infection. vaccinia E3L protein dsRNA-binding protein <br />                                           13 inhibits PKR sequestering dsRNA PKR, preventing binding 56,59.                                           C-terminus vaccinia virus E3L responsible binding dsRNA preventing                                           activating interferon pathway. recent study demonstrated E3L protein                                           functional suppressor RNAi Drosophila cells inactivates RNAi silencing-based <br />                                           antiviral response cells flock house virus infection 39. <br />  <br />                               RNA editing plays role development siRNA resistance NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               mammalian cells <br />                                           Double-stranded RNA induces homology-dependent degradation cognate mRNA                                           cytoplasm RNAi, target <span id='am-20' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-28' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span>adenosine</span> <span id='am-50' about='obo:IMR_0200194' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-51' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasDbXref" content="KEGG:C00294" datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="Inosine" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:id" content="IMR:0200194" datatype="xsd:string"></span>inosine</span>   RNA editing                                           <span id='am-35' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-36' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-49' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span>adenosine</span> deaminases acting RNA (ADARs). RNA editing affects siRNA-mediated <br />                                           RNAi vitro reported Chris Smith&#226;&#8364;&#8482;s group 58, showed production                                           siRNAs progressively inhibited increasing deamination long dsRNA.                                           initial observation immediately supported study C. elegans showed  <br />                                           editing dsRNAs derived transgenes endogenous genes appeared                                           prevent silencing RNAi 30,67. Recent studies demonstrated direct interaction <br />                                           isoforms ADARs siRNA,  ADAR1 ADAR2, strongly <br />                                           bind siRNA RNA editing. ADAR1p110, short form ADAR1 alternative <br />                                           translation initiation codon, ADAR2 bound 19-bp siRNA, binding affinities <br />                                           15 50 times lower ADAR1p150  length ADAR1), respectively. <br />                                           ADAR3 bound longer dsRNAs, failed bind 19-bp siRNA. ADARs                                           capable binding 19-bp siRNA (ADAR1p150 p110 ADAR2) bound siRNAs <br />                                           containing 15- 23-bp dsRNA regions.  length siRNA determines <br />                                           bound siRNA edited held stable complex change sequence; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           critical size threshold appears 30 bp 71. <br />  <br />                                           cytoplasmic length isoform ADAR1 highest affinity siRNA                                           known ADARs, subnanomolar dissociation constant. Gene silencing siRNA                                           significantly effective mouse fibroblasts homozygous ADAR1 null mutation <br />                                           wild-type cells. supported suppression RNAi fibroblast <br />                                           cells overexpressing functional ADAR1, cells overexpressing mutant ADAR1 <br />                                           lacking double-stranded RNA-binding domains. results provide convincing evidence                                           ADAR1 cellular factor limits efficacy siRNA mammalian cells 71. <br />  <br />                               factors lead RNAi resistance mammalian cells <br />                                           described  resistance RNAi viral infection mammalian cells far <br />                                           ascribed major mechanisms: mutations targeted regions expression  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                               Page 6 <br />  <br />  <br />                                           suppressors (Table 1). wonder viruses evolved mechanism(s)                                           counteract initiation RNAi pathway, block pathway&#226;&#8364;&#8482;s intermediate <br />                                           components. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           hypothesis received preliminary support hepatitis delta virus (HDV) <br />                                           study. Data Taylor&#226;&#8364;&#8482;s group indicate HDV RNAs resistant Dicer activity 7. <br />                                           Dicer cleaves RNAs 100% double-stranded, certain RNAs extensive <br />                                           &lt;100% pairing, release RNAs &#226;&#710;&#188;21 nt. circular 1,679-nt genome HDV                                           exact complement, antigenomic RNA, fold rod-like structure 74% pairing, <br />                                           resistance Dicer cleavage. vitro cleavage assay purified recombinant <br />                                           Dicer, &lt;0.2% unit-length HDV RNAs cleaved, Dicer able digest <br />                                           fragments genome. 66-nt hairpin RNA 79% pairing digested &gt;80% <br />                                           cleavage activity, 66-nt hairpin derived end HDV genome                                           digested. data vitro Dicer digestion experiments consistent results <br />                                           small RNAs &#226;&#710;&#188;21 nts detected HDV replication hepatocytes 7.                                           unit-length, highly structured HDV RNAs resist Dicer cleavage suggests viral RNAs <br />                                           evolved prevent initiation RNAi resisting Dicer. HDV itself                                           edited ADAR adenosine 1012 position antigenome 6,52, resistance Dicer                                           RNAi appears unrelated ADAR-mediated editing. <br />  <br />                                           group 1,679-nt genomic antigenomic RNAs HDV NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           resistant siRNA-mediated degradation, viral mRNAs sensitive synthetic <br />                                           siRNA duplexes. thought base-paring HDV genomic antigenomic RNAs <br />                                           nucleus make inaccessible siRNA.  studies                                           HDV circular RNAs transcribed DNA template host RNA polymerase II                                           Huh-7 cells, similar mRNA structure mRNAs 5&#226;&#8364;&#178; cap 3&#226;&#8364;&#178; poly                                           tail, resistant siRNA attack 8. mechanism HDV resistant <br />                                           siRNA remains unknown. <br />  <br />                               Does siRNA activate protein kinase PKR? <br />                                           PKR, mammalian dsRNA-dependent serine-threonine protein kinase, N-terminal <br />                                           dsRNA-binding domain interact non-sequence-specifically long stretches                                           dsRNA, leading activation. activated PKR phosphorylates inactivates translation <br />                                           factor eIF2&#226;&#8364;&#339;, resulting generalized suppression protein synthesis, followed cell death <br />                                           apoptotic nonapoptotic pathways. Activation nonspecific pathway                                           mask sequence-specific effects result RNAi pathway.  <br />                                           successful application RNAi reported mammalian tissue culture cell lines <br />                                           using chemically synthesized siRNAs bypass activation PKR. NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           documented literature small blunt-ended dsRNA 33 bp does activate <br />                                           PKR 45. addition, early studies demonstrated siRNA-mediated inhibition gene <br />                                           expression mammalian cells independent non-specific interference pathways activated <br />                                           larger dsRNAs 5.  recent studies indicate  RNAi mechanism <br />                                           itself independent interferon  transfection 21-bp siRNAs expression                                           shRNAs shRNA vectors does trigger interferon response PKR 2,60.  <br />                                           studies argue siRNAs broad complicating effects selective <br />                                           silencing target genes introduced cells. <br />  <br />                                           effort evaluate contradictory results search possible activators PKR, <br />                                           truncated length versions PKR used select dsRNAs partially <br />                                           structured dsRNA library containing 1011 sequences 76. study identified minimal RNA <br />                                           motif activation PKR. motif hairpin nonconserved, imperfect 16-bp <br />                                           dsRNA stem flanked 11- 15-nt single-stranded tails. Boundary experiments revealed  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                                Page 7 <br />  <br />  <br />                                           single-stranded tails flanking dsRNA core provide critical determinant                                           activation. minimum 11 nts tails needed activation, tails                                           5&#226;&#8364;&#178;-end, 3&#226;&#8364;&#178;-end, 76. group compared dsRNAs lengths 24, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           33, 76 bp PKR binding activation 24-bp dsRNA unable                                           activate PKR; instead, inhibited kinase. Resolution discrepancies                                           findings different study groups require additional biochemical experiments. <br />  <br />                               Closing remarks perspectives <br />                                           entering RNAi era. discovery RNAi C. elegans 21 plants 25                                           revolutionized today&#226;&#8364;&#8482;s approaches biology medicine. actions small <br />                                           pieces dsRNAs (siRNAs miRNAs), RNAi-mediated gene silencing                                           widespread natural phenomenon eukaryotes, powerful experimental <br />                                           tool explore gene function. importantly, potential therapeutic applications. <br />                                           great deal learned past years RNAi pathways                                           functions components, remains understood complete <br />                                           picture RNAi regulated mammalian cells. absolutely doubt RNAi <br />                                           pathways, just like pathways discovered mammalian systems, subject                                           sophisticated regulation (Fig. 2). <br />  <br />                                           RNAi function mammalian cells thought nucleic acid-based antiviral <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           immunity, evidenced recent discovery cellular miR-32 mediates antiviral <br />                                           activities human cells 32. Identification viral RNAi suppressors medically important <br />                                           RNA DNA viruses heralded beginning exploration existing anti-silencing <br />                                           mechanisms virus infection. RNAi suppressors identified far various RNAi <br />                                           reporter assays turn viral dsRNA binding proteins (DRBPs). fewer cellular <br />                                           DRBPs identified viral DRBPs, assume regulate <br />                                           endogenous miRNA siRNA functions cell needed. 300 miRNAs <br />                                           identified genomes humans, viruses, non-human eukaryotic species, <br />                                           abundant (&#226;&#710;&#188; 40,000 copies/cell) 4,41,42,50,51. question                                           examine DRBP&#226;&#8364;&#8482;s suppressive function mammalian  suppressive functions <br />                                           viral RNA suppressors RNAi reporter assays recapitulated vivo <br />                                           viral infections mammals. example, NS1 Influenza virus behaves effective <br />                                           RNAi suppressor Drosophila plant RNAi reporters, play role                                           siRNA-mediated inhibition animal influenza infection 22,66. <br />  <br />                                           388 known eukaryotic proteins dsRNA-binding domains (DRBDs), 72 <br />                                           human 37,62. 20 DRBPs identified reported                                           function diverse range critically important roles cell, including                                            Dicer Ago-2) essential roles RNAi pathways 18,57. proteins harboring <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           DRBDs reported interact little 11 bp dsRNA, event                                           independent nucleotide sequence arrangement 57, conceivable cellular <br />                                           DRBPs actually involved switching function partially double- <br />                                           stranded miRNA  average, targets hundreds mRNAs pairing                                           6-8 bases. ADAR1 factor type interacts siRNAs vitro limits <br />                                           efficacy siRNAs mammalian cells. <br />  <br />                                           intriguing question natural siRNA eukaryotic <br />                                           cells virus infection. RNA viruses dsRNA genome                                           carry single-stranded RNA genome, produce dsRNA intermediates                                           replication. Theoretically, viral dsRNAs substrates Dicer digestion                                           produce siRNAs infected cells.  viral dsRNAs appear resist Dicer digestion, <br />                                           exemplified HDV. production viral siRNAs suppress viral <br />  <br />  <br />                                              Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                                   Page 8 <br />  <br />  <br />                                           gene expression harmful replication virus. Similarly, endogenous siRNA <br />                                           production human genome expected, considering 20% human <br />                                           genes produce antisense transcripts form sense-antisense pairs (dsRNA) 9, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           production endogenous siRNAs human transcripts beneficial                                           human gene expression. Discovering dsRNAs escape Dicer digestion                                           challenge. <br />  <br />                                           Understanding viral RNAi resistance greatly enriched knowledge regulation                                           RNAi pathways. greatly informative know viruses escape RNAi- <br />                                           mediated inhibition counteracting mechanisms: mutations targeted <br />                                           region siRNA selection pressure production RNAi suppressors.  <br />                                           HPV16 use method develop siRNA resistance, proteins                                           appear involved siRNA resistance cells expressing HPV16 E6 E7                                           viral proteins ADAR1. Identification characterization proteins                                           extremely challenging, definitely guide understanding cell <br />                                           counteracts siRNA-mediated events adversely affect survival. siRNAs <br />                                           used potent small-molecule inhibitors cellular gene, best way cell                                           expression genes essential survival develop program                                           resist detrimental effects RNAi. <br />  <br />                               Reference List <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           1. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. Human immunodeficiency virus type 1 escape <br />                                              RNA interference. J. Virol 2003;77:11531&#226;&#8364;&#8220;11535. [PubMed: 14557638] <br />                                           2. Bridge AJ, Pebernard S, Ducraux  Nicoulaz AL, Iggo R. Induction interferon response                                              RNAi vectors mammalian cells. Nat. Genet 2003;34:263&#226;&#8364;&#8220;264. [PubMed: 12796781] <br />                                           3. Bucher E, Hemmes H, Haan P, Goldbach R, Prins M. influenza virus NS1 protein binds <br />                                              small interfering RNAs suppresses RNA silencing plants. J. Gen. Virol 2004;85:983&#226;&#8364;&#8220;991. <br />                                              [PubMed: 15039540] <br />                                           4. Cai X, Lu S, Zhang  Gonzalez CM, Damania B, Cullen BR. Kaposi&#226;&#8364;&#8482;s sarcoma-associated herpesvirus <br />                                              expresses array viral microRNAs latently infected cells. Proc. Natl. Acad. Sci. U. S.                                              2005;102:5570&#226;&#8364;&#8220;5575. [PubMed: 15800047] <br />                                           5. Caplen NJ, Parrish S, Imani F,  Morgan RA. Specific inhibition gene expression small <br />                                              double-stranded RNAs invertebrate vertebrate systems. Proc. Natl. Acad. Sci. U. S.                                              2001;98:9742&#226;&#8364;&#8220;9747. [PubMed: 11481446] <br />                                           6. Casey JL, Gerin JL. Hepatitis D virus RNA editing: specific modification adenosine                                              antigenomic RNA. J. Virol 1995;69:7593&#226;&#8364;&#8220;7600. [PubMed: 7494266] <br />                                           7. Chang J, Provost P, Taylor JM. Resistance human hepatitis delta virus RNAs dicer activity. J. <br />                                              Virol 2003;77:11910&#226;&#8364;&#8220;11917. [PubMed: 14581527] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           8. Chang J, Taylor JM. Susceptibility human hepatitis delta virus RNAs small interfering RNA <br />                                              action. J. Virol 2003;77:9728&#226;&#8364;&#8220;9731. [PubMed: 12915586] <br />                                           9. Chen J, Sun M, Kent WJ, Huang X, Xie H, Wang W, Zhou G, Shi RZ, Rowley JD. 20% human <br />                                              transcripts form sense-antisense pairs. Nucleic Acids Res 2004;32:4812&#226;&#8364;&#8220;4820. [PubMed: <br />                                              15356298] <br />                                           10. Child SJ, Hakki M, Niro KL, Geballe AP. Evasion cellular antiviral responses human <br />                                                cytomegalovirus TRS1 IRS1. J. Virol 2004;78:197&#226;&#8364;&#8220;205. [PubMed: 14671101] <br />                                           11. Coburn GA, Cullen BR. Potent specific inhibition human immunodeficiency virus type 1 <br />                                                replication RNA interference. J. Virol 2002;76:9225&#226;&#8364;&#8220;9231. [PubMed: 12186906] <br />                                           12. Das  Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B. Human <br />                                                immunodeficiency virus type 1 escapes RNA interference-mediated inhibition. J. Virol <br />                                                2004;78:2601&#226;&#8364;&#8220;2605. [PubMed: 14963165] <br />                                           13. Davies MV, Chang HW, Jacobs BL, Kaufman RJ. E3L K3L vaccinia virus gene products <br />                                                stimulate translation inhibition double-stranded RNA-dependent protein kinase                                                different mechanisms. J. Virol 1993;67:1688&#226;&#8364;&#8220;1692. [PubMed: 8094759] <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                                    Page 9 <br />  <br />  <br />                                           14. Delgadillo MO, Saenz P, Salvador B, Garcia JA, Simon-Mateo C. Human influenza virus NS1 protein <br />                                               enhances viral pathogenicity acts RNA silencing suppressor plants. J. Gen. Virol <br />                                               2004;85:993&#226;&#8364;&#8220;999. [PubMed: 15039541] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           15. Ding SW, Li H, Lu R, Li F, Li WX. RNA silencing: conserved antiviral immunity plants                                               animals. Virus Res 2004;102:109&#226;&#8364;&#8220;115. [PubMed: 15068886] <br />                                           16. Doench JG, Petersen CP, Sharp PA. siRNAs function miRNAs. Genes Dev 2003;17:438&#226;&#8364;&#8220;442. <br />                                               [PubMed: 12600936] <br />                                           17. Dougherty JP, Temin HM. Determination rate base-pair substitution insertion mutations <br />                                               retrovirus replication. J. Virol 1988;62:2817&#226;&#8364;&#8220;2822. [PubMed: 2839703] <br />                                           18. Doyle M, Jantsch MF. New old roles double-stranded RNA-binding domain. J. Struct. Biol <br />                                               2002;140:147&#226;&#8364;&#8220;153. [PubMed: 12490163] <br />                                           19. Dykxhoorn DM, Novina CD, Sharp PA. Killing messenger: short RNAs silence gene <br />                                               expression. Nat. Rev. Mol. Cell Biol 2003;4:457&#226;&#8364;&#8220;467. [PubMed: 12778125] <br />                                           20. Elbashir SM, Harborth J, Lendeckel W, Yalcin  Weber K, Tuschl T. Duplexes 21-nucleotide <br />                                               RNAs mediate RNA interference cultured mammalian cells. Nature 2001;411:494&#226;&#8364;&#8220;498. [PubMed: <br />                                               11373684] <br />                                           21.  Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent specific genetic <br />                                               interference double-stranded RNA Caenorhabditis elegans. Nature 1998;391:806&#226;&#8364;&#8220;811. <br />                                               [PubMed: 9486653] <br />                                           22. Ge Q, Filip L, Bai  Nguyen T, Eisen HN, Chen J. Inhibition influenza virus production virus- <br />                                               infected mice RNA interference. Proc. Natl. Acad. Sci. U. S. 2004;101:8676&#226;&#8364;&#8220;8681. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               15173599] <br />                                           23. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity                                               human cells. Nature 2002;418:430&#226;&#8364;&#8220;434. [PubMed: 12087357] <br />                                           24. Gitlin L, Stone JK, Andino R. Poliovirus escape RNA interference: short interfering RNA-target <br />                                               recognition implications therapeutic approaches. J. Virol 2005;79:1027&#226;&#8364;&#8220;1035. [PubMed: <br />                                               15613331] <br />                                           25. Hamilton AJ, Baulcombe DC. species small antisense RNA posttranscriptional gene silencing <br />                                               plants. Science 1999;286:950&#226;&#8364;&#8220;952. [PubMed: 10542148] <br />                                           26. Hammond SM, Bernstein E, Beach D, Hannon GJ. RNA-directed nuclease mediates post- <br />                                               transcriptional gene silencing Drosophila cells. Nature 2000;404:293&#226;&#8364;&#8220;296. [PubMed: 10749213] <br />                                           27. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, link genetic <br />                                               biochemical analyses RNAi. Science 2001;293:1146&#226;&#8364;&#8220;1150. [PubMed: 11498593] <br />                                           28. Hannon GJ. RNA interference. Nature 2002;418:244&#226;&#8364;&#8220;251. [PubMed: 12110901] <br />                                           29. Jacque JM, Triques K, Stevenson M. Modulation HIV-1 replication RNA interference. Nature <br />                                               2002;418:435&#226;&#8364;&#8220;438. [PubMed: 12087358] <br />                                           30. Knight SW, Bass BL. role RNA editing ADARs RNAi. Mol. Cell 2002;10:809&#226;&#8364;&#8220;817. <br />                                               [PubMed: 12419225] <br />                                           31. Krug RM, Yuan W, Noah DL, Latham AG. Intracellular warfare human influenza viruses <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               human cells: roles viral NS1 protein. Virology 2003;309:181&#226;&#8364;&#8220;189. [PubMed: <br />                                               12758165] <br />                                           32. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib  Voinnet O.                                               cellular microRNA mediates antiviral defense human cells. Science 2005;308:557&#226;&#8364;&#8220;560. [PubMed: <br />                                               15845854] <br />                                           33. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani  Salvaterra P, Rossi J. Expression small <br />                                               interfering RNAs targeted HIV-1 rev transcripts human cells. Nat. Biotechnol <br />                                               2002;20:500&#226;&#8364;&#8220;505. [PubMed: 11981565] <br />                                           34. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN.                                               nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415&#226;&#8364;&#8220;419. [PubMed: <br />                                               14508493] <br />                                           35. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing subcellular <br />                                               localization. EMBO J 2002;21:4663&#226;&#8364;&#8220;4670. [PubMed: 12198168] <br />  <br />  <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                                    Page 10 <br />  <br />  <br />                                           36. Leider JM, Palese P, Smith FI. Determination mutation rate retrovirus. J. Virol <br />                                               1988;62:3084&#226;&#8364;&#8220;3091. [PubMed: 2841464] <br />                                           37. Letunic  Copley RR, Schmidt S, Ciccarelli FD, Doerks T, Schultz J, Ponting CP, Bork P. SMART <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               4.0: genomic data integration. Nucleic Acids Res 2004;32:D142&#226;&#8364;&#8220;D144. [PubMed: <br />                                               14681379] <br />                                           38. Li WX, Ding SW. Viral suppressors RNA silencing. Curr. Opin. Biotechnol 2001;12:150&#226;&#8364;&#8220;154. <br />                                               [PubMed: 11287229] <br />                                           39. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, Garcia-Sastre  Ball LA, <br />                                               Palese P, Ding SW. Interferon antagonist proteins influenza vaccinia viruses suppressors <br />                                               RNA silencing. Proc. Natl. Acad. Sci. U. S. 2004;101:1350&#226;&#8364;&#8220;1355. [PubMed: 14745017] <br />                                           40. Lichner  Silhavy D, Burgyan J. Double-stranded RNA-binding proteins suppress RNA <br />                                               interference-mediated antiviral defences. J. Gen. Virol 2003;84:975&#226;&#8364;&#8220;980. [PubMed: 12655099] <br />                                           41. Lim LP, Glasner  Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science <br />                                               2003;299:1540. [PubMed: 12624257] <br />                                           42. Lim LP, Lau NC, Weinstein  Abdelhakim  Yekta S, Rhoades MW, Burge CB, Bartel DP.                                               microRNAs Caenorhabditis elegans. Genes Dev 2003;17:991&#226;&#8364;&#8220;1008. [PubMed: 12672692] <br />                                           43. Lu S, Cullen BR. Adenovirus VA1 noncoding RNA inhibit small interfering RNA MicroRNA <br />                                               biogenesis. J. Virol 2004;78:12868&#226;&#8364;&#8220;12876. [PubMed: 15542639] <br />                                           44. Lund E, Guttinger S, Calado  Dahlberg JE, Kutay U. Nuclear export microRNA precursors. <br />                                               Science 2004;303:95&#226;&#8364;&#8220;98. [PubMed: 14631048] <br />                                           45. Manche L, Green SR, Schmedt C, Mathews MB. Interactions double-stranded RNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               regulators protein kinase DAI. Mol. Cell Biol 1992;12:5238&#226;&#8364;&#8220;5248. [PubMed: 1357546] <br />                                           46. Martinez J, Patkaniowska  Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs <br />                                               guide target RNA cleavage RNAi. Cell 2002;110:563&#226;&#8364;&#8220;574. [PubMed: 12230974] <br />                                           47. Mourelatos  Dostie J, Paushkin S, Sharma  Charroux B, Abel L, Rappsilber J, Mann M, Dreyfuss <br />                                               G. miRNPs: novel class ribonucleoproteins containing numerous microRNAs. Genes Dev <br />                                               2002;16:720&#226;&#8364;&#8220;728. [PubMed: 11914277] <br />                                           48. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman <br />                                               J, Shankar P, Sharp PA. siRNA-directed inhibition HIV-1 infection. Nat. Med 2002;8:681&#226;&#8364;&#8220;686. <br />                                               [PubMed: 12042777] <br />                                           49. Novina CD, Sharp PA. RNAi revolution. Nature 2004;430:161&#226;&#8364;&#8220;164. [PubMed: 15241403] <br />                                           50. Pfeffer S, Sewer  Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, <br />                                               Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan <br />                                               M, Tuschl T. Identification microRNAs herpesvirus family. Nat. Methods 2005;2:269&#226;&#8364;&#8220;276. <br />                                               [PubMed: 15782219] <br />                                           51. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, <br />                                               Tuschl T. Identification virus-encoded microRNAs. Science 2004;304:734&#226;&#8364;&#8220;736. [PubMed: <br />                                               15118162] <br />                                           52. Polson AG, Bass BL, Casey JL. RNA editing hepatitis delta virus antigenome dsRNA-adenosine <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               deaminase. Nature 1996;380:454&#226;&#8364;&#8220;456. [PubMed: 8602246] <br />                                           53. Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O. Ribonuclease activity                                               RNA binding recombinant human Dicer. EMBO J 2002;21:5864&#226;&#8364;&#8220;5874. [PubMed: 12411504] <br />                                           54. Provost P, Silverstein RA, Dishart D, Walfridsson J, Djupedal  Kniola B, Wright  Samuelsson B, <br />                                               Radmark O, Ekwall K. Dicer required chromosome segregation gene silencing fission <br />                                               yeast cells. Proc. Natl. Acad. Sci. U. S. 2002;99:16648&#226;&#8364;&#8220;16653. [PubMed: 12482946] <br />                                           55. Rand TA, Ginalski K, Grishin NV, Wang X. Biochemical identification Argonaute 2 sole <br />                                               protein required RNA-induced silencing complex activity. Proc. Natl. Acad. Sci. U. S.                                               2004;101:14385&#226;&#8364;&#8220;14389. [PubMed: 15452342] <br />                                           56. Romano PR, Zhang F, Tan SL, Garcia-Barrio MT, Katze MG, Dever TE, Hinnebusch AG. Inhibition <br />                                               double-stranded RNA-dependent protein kinase PKR vaccinia virus E3: role complex <br />                                               formation E3 N-terminal domain. Mol. Cell Biol 1998;18:7304&#226;&#8364;&#8220;7316. [PubMed: 9819417] <br />                                           57. Saunders LR, Barber GN. dsRNA binding protein family: critical roles, diverse cellular functions. <br />                                               FASEB J 2003;17:961&#226;&#8364;&#8220;983. [PubMed: 12773480] <br />  <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                                    Page 11 <br />  <br />  <br />                                           58. Scadden AD, Smith CW. RNAi antagonized - hyper-editing. EMBO Rep 2001;2:1107&#226;&#8364;&#8220; <br />                                               1111. [PubMed: 11743024] <br />                                           59. Sharp TV, Moonan F, Romashko  Joshi B, Barber GN, Jagus R. vaccinia virus E3L gene <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               product interacts regulatory substrate binding regions PKR: implications                                               PKR autoregulation. Virology 1998;250:302&#226;&#8364;&#8220;315. [PubMed: 9792841] <br />                                           60. Sledz CA, Holko M, Veer MJ, Silverman RH, Williams BR. Activation interferon                                               short-interfering RNAs. Nat. Cell Biol 2003;5:834&#226;&#8364;&#8220;839. [PubMed: 12942087] <br />                                           61. Soldan SS, Plassmeyer ML, Matukonis MK, Gonzalez-Scarano F. La Crosse virus nonstructural <br />                                               protein NSs counteracts effects short interfering RNA. J. Virol 2005;79:234&#226;&#8364;&#8220;244. [PubMed: <br />                                               15596819] <br />                                           62. Stefl R, Skrisovska L, Allain FH. RNA sequence- shape-dependent recognition proteins                                               ribonucleoprotein particle. EMBO Rep 2005;6:33&#226;&#8364;&#8220;38. [PubMed: 15643449] <br />                                           63. Strijker R, Fritz DT, Levinson AD. Adenovirus VAI-RNA regulates gene expression controlling <br />                                               stability ribosome-bound RNAs. EMBO J 1989;8:2669&#226;&#8364;&#8220;2675. [PubMed: 2583126] <br />                                           64. Svensson C, Akusjarvi G. novel effect adenovirus VA RNA1 cytoplasmic mRNA abundance. <br />                                               Virology 1990;174:613&#226;&#8364;&#8220;617. [PubMed: 2106186] <br />                                           65. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. Adenovirus VAI RNA required                                               efficient translation viral mRNAs late times infection. Cell 1982;31:543&#226;&#8364;&#8220;551. [PubMed: <br />                                               6297772] <br />                                           66. Tompkins SM, Lo CY, Tumpey TM, Epstein SL. Protection lethal influenza virus challenge <br />                                               RNA interference vivo. Proc. Natl. Acad. Sci. U. S. 2004;101:8682&#226;&#8364;&#8220;8686. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               15173583] <br />                                           67. Tonkin LA, Bass BL. Mutations RNAi rescue aberrant chemotaxis ADAR mutants. Science <br />                                               2003;302:1725. [PubMed: 14657490] <br />                                           68. Voinnet O. Induction suppression RNA silencing: insights viral infections. Nat. Rev. <br />                                               Genet 2005;6:206&#226;&#8364;&#8220;220. [PubMed: 15703763] <br />                                           69. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA. Regulation heterochromatic <br />                                               silencing histone H3 lysine-9 methylation RNAi. Science 2002;297:1833&#226;&#8364;&#8220;1837. [PubMed: <br />                                               12193640] <br />                                           70. Wu HL, Huang LR, Huang CC, Lai HL, Liu CJ, Huang YT, Hsu YW, Lu CY, Chen DS, Chen PJ. <br />                                               RNA interference-mediated control hepatitis B virus emergence resistant mutant. <br />                                               Gastroenterology 2005;128:708&#226;&#8364;&#8220;716. [PubMed: 15765406] <br />                                           71. Yang W, Wang Q, Howell KL, Lee JT, Cho DS, Murray JM, Nishikura K. ADAR1 RNA deaminase <br />                                               limits short interfering RNA efficacy mammalian cells. J. Biol. Chem 2005;280:3946&#226;&#8364;&#8220;3953. <br />                                               [PubMed: 15556947] <br />                                           72. Zamore PD. Plant RNAi: viral silencing suppressor inactivates siRNA. Curr. Biol <br />                                               2004;14:R198&#226;&#8364;&#8220;R200. [PubMed: 15028237] <br />                                           73. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs <span id='am-1' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span>ATP</span>-dependent <br />                                               cleavage mRNA 21 23 nucleotide intervals. Cell 2000;101:25&#226;&#8364;&#8220;33. [PubMed: 10778853] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           74. Zeng Y, Yi R, Cullen BR. MicroRNAs small interfering RNAs inhibit mRNA expression                                               similar mechanisms. Proc. Natl. Acad. Sci. U. S. 2003;100:9779&#226;&#8364;&#8220;9784. [PubMed: 12902540] <br />                                           75. Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs <br />                                               termini requirement ATP. EMBO J 2002;21:5875&#226;&#8364;&#8220;5885. [PubMed: 12411505] <br />                                           76. Zheng X, Bevilacqua PC. Activation protein kinase PKR short double-stranded RNAs                                               single-stranded tails. RNA 2004;10:1934&#226;&#8364;&#8220;1945. [PubMed: 15547138] <br />  <br />  <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                             Page 12 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Fig. 1. <br />                                           RNAi mediated synthetic siRNA duplexes depends active cell growth. Efficiencies                                           synthetic p53 siRNA non-specific (NS) siRNA duplexes cellular p53 expression                                           assayed CaSki cells 2 &#195;&#8212; 105 20-24 hours (0 time) plating transient transfection <br />                                           using oligofactamine (Invitrogen). Cell samples prepared 24, 48, 72, 96, 120 <br />                                           hours transfection siRNA (20 nM) diagramed examined Western <br />                                           blot p53 using anti-p53 antibody (Oncogene). Cells (lane 7) (lane 6)  <br />                                           transfection NS p53 siRNAs 96 hours initial siRNA transfection,                                           indicated diagram  compared showed difference responding <br />                                           p53 siRNAs 120 h post initial transfection. <br />  <br />  <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                             Zheng et al.                                                                                     Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Fig. 2. <br />                                           RNAi pathways RNAi resistance. Despite different origins, siRNA                                           microRNA similar effects mRNA expression RISC-mediated activities. <br />                                           Development RNAi resistance mammalian cells possible blocks <br />                                           (-) RNAi pathways. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Ann N Y Acad Sci. Author manuscript; available PMC 2006 17. <br />                                  Zheng et al.                                                                                                   Page 14 <br />  <br />                                                                                              Table 1. <br />                                 Mechanisms development resistance RNAi mammalian cells <br />  <br />                            RNAi-resistance                       Mutation target           Production suppressors   Cellular proteins <br />                                                                           regions <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            RNA viruses <br />                            Poliovirus                                        Yes <br />                            HIV-1                                             Yes <br />                            La Crosse                                         Yes                               NSs <br />                            PFV-1                                                                               Tas <br />                            Influenza                                 <br /> </body></html>